X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (82) 82
humans (76) 76
female (53) 53
middle aged (44) 44
male (42) 42
abridged index medicus (39) 39
aged (38) 38
risk factors (35) 35
stroke (29) 29
medicine, general & internal (28) 28
adult (25) 25
risk (25) 25
insulin resistance (19) 19
clinical trials (17) 17
pioglitazone (17) 17
prevention (17) 17
prognosis (17) 17
health aspects (15) 15
infectious diseases (15) 15
double-blind method (14) 14
mortality (14) 14
peripheral vascular disease (14) 14
clinical neurology (13) 13
cohort studies (13) 13
public, environmental & occupational health (12) 12
stroke - prevention & control (12) 12
myocardial infarction (11) 11
transient ischemic attack (11) 11
treatment outcome (11) 11
hypoglycemic agents - therapeutic use (10) 10
secondary prevention (10) 10
aged, 80 and over (9) 9
drug therapy (9) 9
patients (9) 9
recurrence (9) 9
analysis (8) 8
cancer (8) 8
care and treatment (8) 8
evaluation (8) 8
hematology (8) 8
insulin (8) 8
ischemic attack, transient - physiopathology (8) 8
logistic models (8) 8
microbiology (8) 8
randomized controlled trials as topic (8) 8
risk-factors (8) 8
stroke - drug therapy (8) 8
adolescent (7) 7
article (7) 7
ischemia (7) 7
ischemic attack, transient - drug therapy (7) 7
life sciences (7) 7
medical research (7) 7
myocardial infarction - mortality (7) 7
patient compliance (7) 7
research (7) 7
severity of illness index (7) 7
stroke - physiopathology (7) 7
thiazolidinediones - therapeutic use (7) 7
united states (7) 7
cardiac & cardiovascular systems (6) 6
case-control studies (6) 6
cerebral infarction (6) 6
cerebrovascular disorders (6) 6
clinical-trial (6) 6
diabetes (6) 6
follow-up studies (6) 6
health risks (6) 6
odds ratio (6) 6
prospective studies (6) 6
research design (6) 6
sex factors (6) 6
time factors (6) 6
acute lymphoblastic-leukemia (5) 5
age factors (5) 5
association (5) 5
bone-marrow-transplantation (5) 5
cardiovascular-disease (5) 5
comorbidity (5) 5
endocrinology & metabolism (5) 5
heart attack (5) 5
hospitalization (5) 5
human health and pathology (5) 5
insulin-resistance (5) 5
ischemic stroke (5) 5
leukemia (5) 5
macrovascular events (5) 5
management (5) 5
myocardial infarction - drug therapy (5) 5
myocardial infarction - prevention & control (5) 5
pharmacology & pharmacy (5) 5
regression analysis (5) 5
stroke - diagnosis (5) 5
surgery (5) 5
survival (5) 5
transplantation (5) 5
women (5) 5
blood pressure (4) 4
cardiovascular disease (4) 4
cerebral ischemia (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Stroke, ISSN 0039-2499, 01/2018, Volume 49, Issue Suppl_1
Journal Article
New England Journal of Medicine, ISSN 0028-4793, 08/2016, Volume 375, Issue 7, p. 704
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2016, Volume 374, Issue 14, pp. 1321 - 1331
Journal Article
Academic Medicine, ISSN 1040-2446, 2006, Volume 81, Issue 5, pp. 476 - 482
Journal Article
Journal Article
American Heart Journal, ISSN 0002-8703, 2014, Volume 168, Issue 6, pp. 823 - 829.e6
Journal Article
Journal of Clinical Epidemiology, ISSN 0895-4356, 03/2019, Volume 107, pp. 129 - 129
Journal Article
International Journal of Stroke, ISSN 1747-4930, 8/2019, Volume 14, Issue 6, pp. 639 - 645
Background The obesity paradox refers to the finding in observational studies that patients with obesity have a better prognosis after stroke than normal... 
metabolic syndrome | Obesity | obesity paradox | insulin resistance | prognosis | stroke | Index Medicus
Journal Article
Journal Article
Journal of the American Medical Association, ISSN 0098-7484, 05/1996, Volume 275, Issue 19, pp. 1489 - 1494
Journal Article
Circulation, ISSN 0009-7322, 05/2017, Volume 135, Issue 20, pp. 1882 - 1893
Journal Article
DIABETES, ISSN 0012-1797, 07/2018, Volume 67, Issue Supplement 1, p. 17
In the Insulin Resistance Intervention after Stroke (IRIS) trial, pioglitazone (PIO) reduced the risk of fatal/nonfatal stroke/MI by 24% vs. placebo (PLA) in... 
ENDOCRINOLOGY & METABOLISM | Transient ischemic attack | Ischemia | Pioglitazone | Cardiovascular disease | Insulin resistance | Lipids | Diabetes | Patients | Insulin | Lipoproteins (high density)
Conference Proceeding